← Eichor
Condition: Active Moderate To Severe Rheumatoid Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Moderate To Severe Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severel
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07423533The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07001956A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Phase 2 · 104 location(s) · AbbVie · NCT06972446Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Phase 1 · 7 location(s) · Lifordi Immunotherapeutics, Inc. · NCT07207954Korean Post-marketing Surveillance for Xeljanz XR
Phase N/A · 1 location(s) · Pfizer · NCT04876781A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Phase 1 · 11 location(s) · Cullinan Therapeutics Inc. · NCT07041099Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Phase 2 · 6 location(s) · Toll Biotech Co. Ltd. (Beijing) · NCT07408024Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Trea
Phase 4 · 1 location(s) · Shaikh Zayed Hospital, Lahore · NCT07554820A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · 144 location(s) · AstraZeneca · NCT07276581
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.